Skip to content
PICO Portalanswers from OpenAlex

Serum leucine-rich alpha-2 glycoprotein is a disease activity biomarker in ulcerative colitis

PaperCitations, authors & open-access status

Serum leucine-rich alpha-2 glycoprotein is a disease activity biomarker in ulcerative colitis is a paper indexed in PICO Portal from OpenAlex.

How many citations does Serum leucine-rich alpha-2 glycoprotein is a disease activity biomarker in ulcerative colitis have?

PICO Portalcitation count

Serum leucine-rich alpha-2 glycoprotein is a disease activity biomarker in ulcerative colitis has 230 citations in the OpenAlex counts PICO Portal stores.

When was Serum leucine-rich alpha-2 glycoprotein is a disease activity biomarker in ulcerative colitis published?

PICO Portalyear

Serum leucine-rich alpha-2 glycoprotein is a disease activity biomarker in ulcerative colitis has 2012 year in the PICO Portal index.

What is the open-access status of Serum leucine-rich alpha-2 glycoprotein is a disease activity biomarker in ulcerative colitis?

PICO Portaloa status

Serum leucine-rich alpha-2 glycoprotein is a disease activity biomarker in ulcerative colitis has bronze oa status in the PICO Portal index.

What is the DOI of Serum leucine-rich alpha-2 glycoprotein is a disease activity biomarker in ulcerative colitis?

PICO Portaldoi

The DOI for Serum leucine-rich alpha-2 glycoprotein is a disease activity biomarker in ulcerative colitis is on the source record.

What is the PMID of Serum leucine-rich alpha-2 glycoprotein is a disease activity biomarker in ulcerative colitis?

PICO Portalpmid

The PMID for Serum leucine-rich alpha-2 glycoprotein is a disease activity biomarker in ulcerative colitis is on the source record.

What is the OpenAlex record for Serum leucine-rich alpha-2 glycoprotein is a disease activity biomarker in ulcerative colitis?

PICO Portalopenalex

The OpenAlex for Serum leucine-rich alpha-2 glycoprotein is a disease activity biomarker in ulcerative colitis is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial